1. Home
  2. FNWB vs GNLX Comparison

FNWB vs GNLX Comparison

Compare FNWB & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

HOLD

Current Price

$9.40

Market Cap

83.1M

Sector

Finance

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$3.42

Market Cap

202.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWB
GNLX
Founded
1923
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.1M
202.4M
IPO Year
2015
2023

Fundamental Metrics

Financial Performance
Metric
FNWB
GNLX
Price
$9.40
$3.42
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$13.50
$19.75
AVG Volume (30 Days)
40.8K
135.3K
Earning Date
01-28-2026
11-05-2025
Dividend Yield
1.51%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$54,052,000.00
N/A
Revenue This Year
$31.86
N/A
Revenue Next Year
$10.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.47
N/A
52 Week Low
$6.05
$1.99
52 Week High
$12.10
$8.54

Technical Indicators

Market Signals
Indicator
FNWB
GNLX
Relative Strength Index (RSI) 43.19 28.76
Support Level $9.26 $3.32
Resistance Level $9.48 $4.99
Average True Range (ATR) 0.15 0.34
MACD -0.08 -0.05
Stochastic Oscillator 23.65 6.59

Price Performance

Historical Comparison
FNWB
GNLX

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: